senicapoc has been researched along with piracetam in 3 studies
| Studies (senicapoc) | Trials (senicapoc) | Recent Studies (post-2010) (senicapoc) | Studies (piracetam) | Trials (piracetam) | Recent Studies (post-2010) (piracetam) |
|---|---|---|---|---|---|
| 42 | 3 | 32 | 3,345 | 557 | 1,169 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballas, SK; Nagalla, S | 3 |
3 review(s) available for senicapoc and piracetam
| Article | Year |
|---|---|
Drugs for preventing red blood cell dehydration in people with sickle cell disease.
Topics: Acetamides; Anemia, Sickle Cell; Antisickling Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dehydration; Early Termination of Clinical Trials; Erythrocyte Aging; Erythrocytes; Humans; Piracetam; Randomized Controlled Trials as Topic; Trityl Compounds; Zinc Sulfate | 2012 |
Drugs for preventing red blood cell dehydration in people with sickle cell disease.
Topics: Acetamides; Anemia, Sickle Cell; Antisickling Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dehydration; Early Termination of Clinical Trials; Erythrocyte Aging; Erythrocytes; Humans; Piracetam; Randomized Controlled Trials as Topic; Trityl Compounds; Zinc Sulfate | 2016 |
Drugs for preventing red blood cell dehydration in people with sickle cell disease.
Topics: Acetamides; Anemia, Sickle Cell; Antisickling Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dehydration; Early Termination of Clinical Trials; Erythrocyte Aging; Erythrocytes; Humans; Piracetam; Quality of Life; Randomized Controlled Trials as Topic; Trityl Compounds; Zinc Sulfate | 2018 |